NO20083521L - Rimonabantmonohydrat, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende samme - Google Patents

Rimonabantmonohydrat, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende samme

Info

Publication number
NO20083521L
NO20083521L NO20083521A NO20083521A NO20083521L NO 20083521 L NO20083521 L NO 20083521L NO 20083521 A NO20083521 A NO 20083521A NO 20083521 A NO20083521 A NO 20083521A NO 20083521 L NO20083521 L NO 20083521L
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
same
rimonabant monohydrate
Prior art date
Application number
NO20083521A
Other languages
English (en)
Inventor
Olivier Monnier
Gerard Coquerel
Baptiste Fours
Helene Duplaa
Philippe Ochsenbein
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083521(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20083521L publication Critical patent/NO20083521L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Den foreliggende oppfinnelse vedrører rimonabantmonohydrat, fremgangsmåten for å preparere denne og farmasøytiske preparater som inneholder den.
NO20083521A 2006-02-08 2008-08-13 Rimonabantmonohydrat, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende samme NO20083521L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601253A FR2897060B1 (fr) 2006-02-08 2006-02-08 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
PCT/FR2007/000201 WO2007090949A1 (fr) 2006-02-08 2007-02-05 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Publications (1)

Publication Number Publication Date
NO20083521L true NO20083521L (no) 2008-10-24

Family

ID=37075667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083521A NO20083521L (no) 2006-02-08 2008-08-13 Rimonabantmonohydrat, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger inneholdende samme

Country Status (20)

Country Link
US (1) US20090048449A1 (no)
EP (1) EP1984341A1 (no)
JP (1) JP2009526025A (no)
KR (1) KR20080093042A (no)
CN (1) CN101405271A (no)
AR (1) AR059327A1 (no)
AU (1) AU2007213649A1 (no)
BR (1) BRPI0707711A2 (no)
CA (1) CA2641494A1 (no)
DO (1) DOP2007000023A (no)
EA (1) EA200870236A1 (no)
FR (1) FR2897060B1 (no)
GT (1) GT200700014A (no)
IL (1) IL192963A0 (no)
MA (1) MA30312B1 (no)
NO (1) NO20083521L (no)
TW (1) TW200804343A (no)
UY (1) UY30137A1 (no)
WO (1) WO2007090949A1 (no)
ZA (1) ZA200806713B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008026219A2 (en) * 2006-09-01 2008-03-06 Hetero Drugs Limited Novel polymorphs of rimonabant
WO2008056377A2 (en) * 2006-11-06 2008-05-15 Cadila Healthcare Limited Polymorphic forms of rimonabant
CN110922366B (zh) * 2014-12-08 2023-02-03 苏州晶云药物科技股份有限公司 一种包含缬沙坦和ahu377的三钠盐超分子复合物的新晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2831883B1 (fr) * 2001-11-08 2004-07-23 Sanofi Synthelabo Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
JP4746931B2 (ja) * 2005-07-22 2011-08-10 株式会社日立製作所 フラットディスプレイパネルモジュール及びフラットディスプレイ装置
WO2008026219A2 (en) * 2006-09-01 2008-03-06 Hetero Drugs Limited Novel polymorphs of rimonabant
WO2008035023A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Polymorphs of rimonabant

Also Published As

Publication number Publication date
EP1984341A1 (fr) 2008-10-29
TW200804343A (en) 2008-01-16
WO2007090949A1 (fr) 2007-08-16
US20090048449A1 (en) 2009-02-19
FR2897060B1 (fr) 2008-07-25
JP2009526025A (ja) 2009-07-16
GT200700014A (es) 2007-09-19
AU2007213649A1 (en) 2007-08-16
FR2897060A1 (fr) 2007-08-10
KR20080093042A (ko) 2008-10-17
BRPI0707711A2 (pt) 2011-05-10
UY30137A1 (es) 2007-09-28
ZA200806713B (en) 2009-10-28
DOP2007000023A (es) 2008-02-15
EA200870236A1 (ru) 2009-02-27
AR059327A1 (es) 2008-03-26
MA30312B1 (fr) 2009-04-01
CA2641494A1 (fr) 2007-08-16
CN101405271A (zh) 2009-04-08
IL192963A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA200970156A1 (ru) Пиридизиноновые производные
NO20084878L (no) Humanisert C-kit antistoff
NO20090295L (no) Substituerte heteroarylderivater
WO2008005877A3 (en) Inhibitors of c-kit and uses thereof
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
GEP20135925B (en) Inhibitors of hedgehog pathway
NO20084435L (no) C-MET proteinkinaseinhibitorer
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA201170772A1 (ru) Органические соединения
NO20090596L (no) Antivirale fosfinatforbindelser
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
MY153915A (en) Organic compounds
ATE497961T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen
NO20084747L (no) Tetrahydropteridiner anvendbare som inhibitorer av protein kinaser
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
UA100190C2 (en) Akt and p70 s6 kinase inhibitors
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
WO2008061108A3 (en) Phthalazine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application